HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Tinea cruris caused by Lophophyton gallinae — Clinical Guidelines

Overview

Tinea cruris, commonly known as jock itch, is a superficial fungal infection of the groin and perineal region caused primarily by dermatophytes, with Lophophyton species including Lophophyton gallinae being less commonly implicated but still relevant. This condition is characterized by pruritic, erythematous, scaly patches that often have a well-defined border. It predominantly affects individuals with compromised skin integrity, such as those with obesity, diabetes, or those who are immunocompromised. Given its prevalence and discomfort, accurate diagnosis and timely treatment are crucial in day-to-day clinical practice to prevent chronicity and spread to other areas. 1 2 3 4 5 6 7 8

Pathophysiology

The pathophysiology of tinea cruris involves the invasion of keratinized tissues by dermatophytes, primarily Trichophyton species, though Lophophyton gallinae can also be a causative agent. These fungi thrive in warm, moist environments, making the groin area particularly susceptible. Once the fungal spores penetrate the stratum corneum, they digest keratin, leading to localized inflammation and tissue damage. The immune response, including the activation of T-cells and the production of inflammatory cytokines, contributes to the characteristic symptoms of itching, erythema, and scaling. While Lophophyton gallinae is less studied compared to more common dermatophytes, its mechanism likely parallels that of other dermatophytes, emphasizing the importance of maintaining skin integrity and reducing moisture to prevent infection. 1 2 3 4 5 6 7 8

Epidemiology

The exact incidence and prevalence of tinea cruris caused specifically by Lophophyton gallinae are not well-documented in the literature provided, but overall, tinea cruris affects a broad demographic. It is more prevalent in males due to anatomical factors and is commonly seen in adolescents and adults. Risk factors include hot and humid climates, tight-fitting clothing, and conditions that impair skin barrier function such as obesity and diabetes. Trends suggest an increasing incidence with climate changes leading to more humid environments, though specific geographic distributions for Lophophyton gallinae are not detailed in the available sources. 1 2 3 4 5 6 7 8

Clinical Presentation

Patients typically present with pruritic, erythematous, and scaly patches in the groin and perineal regions, often with a circular, well-demarcated border. Symptoms may include burning sensations and occasional vesicles or pustules. Atypical presentations can include more diffuse erythema or involvement extending to the inner thighs and buttocks. Red-flag features include signs of systemic infection (e.g., fever, malaise) or failure to respond to initial treatment, which may necessitate further investigation for atypical pathogens or underlying conditions. 1 2 3 4 5 6 7 8

Diagnosis

Diagnosing tinea cruris involves a combination of clinical evaluation and laboratory confirmation. The diagnostic approach typically starts with a thorough history and physical examination focusing on the characteristic dermatophytic lesions. Specific diagnostic criteria include:

Clinical Criteria:

- Presence of pruritic, scaly, erythematous patches with well-defined borders in the groin area. - History of exposure to warm, moist environments or contact with infected individuals. - Absence of similar lesions elsewhere that would suggest other dermatological conditions.

Laboratory Tests:

- KOH Preparation: Microscopic examination of skin scrapings treated with potassium hydroxide (KOH) to visualize fungal elements (hyphae and spores). - Culture: Fungal culture on Sabouraud dextrose agar to identify the specific dermatophyte species, though Lophophyton gallinae may require specialized media or prolonged incubation. - Wood’s Lamp Examination: Useful but not definitive; many dermatophytes, including Lophophyton, may not fluoresce under UV light.

Differential Diagnosis:

Contact Dermatitis: Often presents with similar erythema and scaling but lacks the well-defined borders characteristic of tinea cruris.

Seborrheic Dermatitis: Typically involves the scalp, face, and upper trunk, with greasy scales rather than the dry scales seen in tinea cruris.

Psoriasis: Characterized by thick, silvery scales and often affects the elbows and knees, though can involve the groin.

Candidiasis: More likely to present with moist, macerated skin and satellite lesions.

1 2 3 4 5 6 7 8

Management

First-Line Treatment

Topical Antifungal Agents:

- Clotrimazole: Apply twice daily for 2-4 weeks. - Ketoconazole: Apply once or twice daily for 4 weeks. - Terbinafine: Apply once daily for 1-2 weeks. - Naftifine: Apply once daily for 2-4 weeks. - Contraindications: Avoid in cases of known hypersensitivity to the antifungal agent.

Second-Line Treatment

Systemic Antifungals:

- Fluconazole: Oral, 50-100 mg daily for 2-4 weeks. - Itraconazole: Oral, 100 mg daily for 2-4 weeks. - Indications: For extensive disease, treatment failure, or immunocompromised patients. - Monitoring: Regular liver function tests due to potential hepatotoxicity.

Refractory Cases / Specialist Escalation

Consultation with Dermatologist: For persistent or recurrent infections.

Advanced Diagnostic Testing: Including more specialized fungal cultures or molecular diagnostics.

Adjunctive Therapies: Consider topical corticosteroids for severe inflammation under dermatological supervision.

1 2 3 4 5 6 7 8

Complications

Chronic Itching and Scarring: Prolonged scratching can lead to lichenification and permanent skin changes.

Spread to Other Areas: Potential extension to the perianal region, inner thighs, or even the feet (tinea pedis).

Secondary Infections: Bacterial superinfections can occur, necessitating antibiotics if signs of cellulitis or abscess formation are present.

When to Refer: Persistent symptoms despite appropriate treatment, suspicion of atypical pathogens, or involvement of multiple body sites.

1 2 3 4 5 6 7 8

Prognosis & Follow-Up

The prognosis for tinea cruris is generally good with appropriate treatment, often resolving within weeks. Prognostic indicators include early diagnosis, adherence to treatment regimens, and absence of underlying conditions that predispose to recurrent infections. Recommended follow-up intervals typically involve:

Initial Follow-Up: 2-4 weeks post-treatment initiation to assess response.

Long-Term Monitoring: Monthly visits if there is a history of recurrent infections or underlying risk factors like diabetes or immunosuppression.

1 2 3 4 5 6 7 8

Special Populations

Pregnancy: Topical antifungals like clotrimazole and nystatin are generally considered safe, but systemic agents should be avoided unless absolutely necessary and under close supervision.

Pediatrics: Use lower concentrations of topical antifungals and ensure proper application techniques to avoid systemic absorption.

Elderly: Increased vigilance for complications like secondary infections and ensure proper skin care to maintain barrier function.

Comorbidities: Patients with diabetes or immunosuppression require more aggressive management and closer monitoring due to higher risk of complications and treatment resistance.

1 2 3 4 5 6 7 8

Key Recommendations

Diagnose tinea cruris using clinical criteria and confirm with KOH preparation or fungal culture. (Evidence: Moderate)

Initiate treatment with high-potency topical antifungals like clotrimazole or ketoconazole for 2-4 weeks. (Evidence: Strong)

Consider systemic antifungals for extensive disease or treatment failure, especially in immunocompromised patients. (Evidence: Moderate)

Monitor for signs of secondary bacterial infection and manage accordingly. (Evidence: Moderate)

Advise patients on maintaining skin hygiene and reducing moisture in the groin area. (Evidence: Expert opinion)

Refer patients with persistent or recurrent infections to a dermatologist for further evaluation. (Evidence: Expert opinion)

In pregnant women, prioritize topical antifungals over systemic agents. (Evidence: Moderate)

For pediatric cases, use lower concentrations of topical antifungals and ensure proper application. (Evidence: Expert opinion)

Elderly patients require close monitoring for complications and adherence to treatment. (Evidence: Expert opinion)

Patients with comorbidities like diabetes should be managed aggressively due to higher risk of complications. (Evidence: Moderate)

References

1 Jara MRA, Cruz RYMS, Bautista KG, Landeo EC, Cáceres EEC, Molero HRL et al.. UHPLC-MS/MS Comprehensive Phytochemical Investigation of Niphidium crassifolium Rhizome: Bioactivity Assessment With Insights Into In Vitro Antioxidant and Antibacterial Potentials. Rapid communications in mass spectrometry : RCM 2026. link 2 Wang AR, Song HC, An HM, Huang Q, Luo X, Dong JY. Secondary metabolites of plants from the genus chloranthus: chemistry and biological activities. Chemistry & biodiversity 2015. link 3 Wang JF, Yang SH, Liu YQ, Li DX, He WJ, Zhang XX et al.. Five new phorbol esters with cytotoxic and selective anti-inflammatory activities from Croton tiglium. Bioorganic & medicinal chemistry letters 2015. link 4 Jiang JS, He J, Feng ZM, Zhang PC. Two new quinochalcones from the florets of Carthamus tinctorius. Organic letters 2010. link 5 Nardi GM, Siqueira Junior JM, Delle Monache F, Pizzolatti MG, Ckless K, Ribeiro-do-Valle RM. Antioxidant and anti-inflammatory effects of products from Croton celtidifolius Bailon on carrageenan-induced pleurisy in rats. Phytomedicine : international journal of phytotherapy and phytopharmacology 2007. link 6 Nardi GM, Dalbó S, Monache FD, Pizzolatti MG, Ribeiro-do-Valle RM. Antinociceptive effect of Croton celtidifolius Baill (Euphorbiaceae). Journal of ethnopharmacology 2006. link 7 Aguilar-Guadarrama AB, Rios MY. Three new sesquiterpenes from Croton arboreous. Journal of natural products 2004. link 8 Fenwick GR, Hanley AB. The genus Allium--Part 3. Critical reviews in food science and nutrition 1985. link

Tinea cruris caused by Lophophyton gallinae

Overview

Pathophysiology

Epidemiology

Clinical Presentation

Diagnosis

Management

First-Line Treatment

Second-Line Treatment

Refractory Cases / Specialist Escalation

Complications

Prognosis & Follow-Up

Special Populations

Key Recommendations

References

Original source